Merck Announces Third-Quarter 2018 Dividend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- Japan has no plans to overhaul pension funds' asset allocation, sources say
Goldman Sachs Says Merck (MRK) 'Likely to be the Dominant Player in All of NSCLC'
May 23, 2018 9:26 AM EDTMerck (NYSE: MRK) announced that its phase 3 trial in 1L squamous NSCLC, KN-407 met its dual primary endpoint of OS and PFS based on an interim analysis conducted by the DMC. Goldman Sachs expects full data at ASCO and anticipated this update after... More
